V. Raina

Publications325
h-index31
Citations6,239
Highly Influential Citations206
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • L. Kumar
  • 656 Publications • 5,531 Citations
  • M. Untch
  • 844 Publications • 46,385 Citations
  • B. Mohanti
  • 299 Publications • 2,987 Citations
  • H. Kantarjian
  • 4,837 Publications • 221,563 Citations
  • Publications
  • Influence
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Prevalence and risk factors for development of lymphedema following breast cancer treatment.
TLDR
Post treatment lymphedema continues to be a significant problem following breast cancer therapy and a combination of axillary dissection and axillary radiation should be avoided whenever feasible to avoid lyMPhedema.
Lipid peroxidation, free radical production and antioxidant status in breast cancer
TLDR
Results of the study have shown a higher ROMs production and decreased CAT activity, which support the oxidative stress hypothesis in carcinogenesis and administration of CAT may be helpful in the management of BC patients.
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.
TLDR
This randomized controlled trial confirmed the efficacy of chemotherapy (mGEMOX) compared with BSC and FUFA in improving OS and PFS in unresectable GBC.
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016
Clinico-pathological profile of lung cancer at AIIMS: a changing paradigm in India.
TLDR
This analysis suggests that adenocarcinoma may now be the commonest histological subtype of non-small cell lung cancer in India, provided a careful pathological review is done.
Clinical features and prognostic factors of early breast cancer at a major cancer center in North India.
TLDR
The median age at presentation was 47 years, significantly lower than most Western figures, and nodal involvement was the significant prognostic factor for overall and disease-free survival.
Lung cancer: Prevalent trends & emerging concepts
TLDR
The time trends of lung cancer show a significant rise in Delhi, Chennai and Bengaluru in both sexes and the applicability of such screening tool is questionable, development of newer non invasive methods/ biomarkers for early diagnosis and screening of high risk population is warranted.
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer.
...
1
2
3
4
5
...